Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DGAP-AGM: Fresenius SE & Co. KGaA: Announcement -11-

04/07/2021 | 11:51am EDT
 1997 - 1999                          Harvard Medical International Association Institution Dresden 
                                      Director, founder and dean 
 
 
 
 1994 - 1997                          Technical University of Dresden 
                                      Appointment as a C4-Professor in anesthesiology and intensive care 
 
 
 
                                      University of Heidelberg 
                                      1992 - 1994 Director and Founder Center for Medical Research 
 1989 - 1994 
                                      1989 - 1992 appointment as C3-Professor for anesthesiology; Deputy Medical 
                                      Director of the clinic for anesthesiology and intensive care 
 
 Education 
 
 
 
 1989                                 University of Lübeck 
                                      Habilitation in medicine (Prof. Dr. med.) 
 
 
 
 1985                                 LMU Munich 
                                      Doctorate in medicine (Dr. med.) 
 
 
 
 1971 - 1976                          LMU Munich 
                                      Studies of medicine 
 
 
 
 Membership of other statutory 
 supervisory boards 
 
 
 
 Dresden International University 
 (DIU) 
 
 University Hospital Aachen 
 
 
 
 Membership of comparable German or 
 foreign supervisory bodies 
 

None The Fresenius Group maintains a regular business relationship with the University Hospital Carl Gustav Carus, Dresden, at market conditions. In the fiscal year 2020, the total transaction volume with the University Hospital Carl Gustav Carus, Dresden, was less than 1% of the group turnover of Fresenius SE & Co. KGaA. b) Michael Diekmann Member of various supervisory boards Deputy Chairman of the Supervisory Board of Fresenius SE & Co. KGaA since 2015

Date of Birth: December 23, 1954 Place of Birth: Bielefeld Nationality: German

 
 
 
 
 Professional Experience 
 
 
 
 2003 - 2015             Allianz SE (formerly Allianz AG) 
                         Chairman of the Management Board 
 
 
 
 1998 - 2003             Allianz AG 
                         Member of the Management Board 
 
 
 
 1988 - 1998             Allianz Versicherungs-AG 
 
 1983 - 1988             Diekmann/Thieme GbR (publishing house) 
 
                         CEO 
 
 
 
 Education 
 
 
 
 1973 - 1982   University of Göttingen 
               Studies in Law and Philosophy 
 
 
 
 
 
 Membership of other statutory supervisory boards 
 
 
 
 Allianz SE^1 (Chair) 
 
 Fresenius Management SE (Fresenius Group mandate) 
 
 Siemens AG^1 
 
 
 
 
 
 Membership of comparable German or foreign supervisory bodies 
 
 None 
 
 
 

^1 Stock listed company

c) Wolfgang Kirsch Member of various supervisory boards

Date of Birth: March 19, 1955 Place of Birth: Bensberg Nationality: German

 
 
 
 
 Professional 
 Experience 
 
 
 
                    DZ BANK AG 
                    2006 - 2018 Chief Executive Officer 
 2002 - 2018 
                    2005 - 2006 Deputy Chief Executive Officer 
 
                    2002 - 2005 Member of the Board of Managing Directors 
 
 
 
                    Deutsche Bank AG, Frankfurt 
 2000 - 2002        Managing Director and Senior Credit Executive of the Corporates and Real Estate Division and CIB 
                    Corporate and Investment Bank 
 
 1998 - 2000        Deutsche Bank, Singapore 
                    General Manager and Chief Country Officer 
 
 1981 - 1998        Deutsche Bank AG, Düsseldorf and Frankfurt 
                    various positons within the Corporate and Investment Banking Division 
 
 
 
 
 
 Education 
 
 
 
 1977 - 1981                                                   Universität Köln 
                                                               Business Administration (Diplom-Kaufmann) 
 
 
 
 1975 - 1977                                                   Deutsche Bank AG 
                                                               Banking apprenticeship 
 
 
 Membership of other statutory supervisory boards 
 
 Adolf Würth GmbH & Co. KG 
 
 Fresenius Management SE (Fresenius Group mandate) 
 
 
 
 Membership of comparable German or foreign supervisory bodies 
 
 
 

AGCO Corporation^1, USA (until 04/2021)

^1 Stock listed company

d) Prof. Dr. med. Iris Löw-Friedrich Chief Medical Officer and Executive Vice President, Head of Development, UCB S.A.

Member of the Supervisory Board of Fresenius SE & Co. KGaA since 2016

Date of Birth: November 17, 1960 Place of Birth: Offenbach / Main Nationality: German

 
 
 
 
 Professional Experience 
 
 
 
 2008 - today            UCB S.A 
                         Chief Medical Officer and Executive Vice President Development 
 
 
 
 2001 - 2009             Schwarz Pharma AG 
                         Member of the Executive Board, Head of Research and Development 
 
 
 
 2000 - 2001             BASF Pharma 
                         Vice President Global Projects 
 
 
 
 1992 - 2000             Hoechst AG 
                         Various positions, last serving as Vice President Clinical Development 
 
 
 
 Education 
 
 
 
 since 2000    University of Frankfurt am Main 
               Professor for internal medicine 
 
 
 
 1985          University of Frankfurt am Main 
               Doctorate in medicine (Dr. med.) 
 
 
 
 1979 - 1985   University of Frankfurt am Main 
               Studies of medicine 
 
 
 Membership of other statutory supervisory boards 

Evotec AG^1

Membership of comparable German or foreign supervisory bodies

 
 
 
 
 None 
 

The Fresenius Group maintains a business relationship with UCB S.A. at market conditions. In the fiscal year 2020 the total transaction volume with UCB S.A. was less than 1% of the group turnover of Fresenius SE & Co. KGaA.

^1 Stock listed company

e) Klaus-Peter Müller Honorary Chairman of the Supervisory Board of Commerzbank AG

Member of the Supervisory Board since 2008

Date of Birth: September 16, 1944 Place of Birth: Duppach Nationality: German

 
 
 
 
 Professional Experience 
 
 
 
                         Commerzbank AG 
 1990 - 2008             2001 - 2008 Chairman of the Management Board 
                         1990 - 2001 Member of the Management Board 
 
 
 
                         Commerzbank AG 
                         Head of the department in charge of the bank's East German operations 
 
                         Executive Vice President / Head of corporate banking department 
 
 1966 - 1990             Joint Manager of the New York branch 
 
                         Düsseldorf branch, later joint manager of the Duisburg branch 
 
                         Representative Office (later branch) in New York 
 
                         Düsseldorf branch 
 
 
 
 
 
 Education 
 
 
 
 1964 - 1966   Military Service (1st. Lt.) 
 
 
 
 1962 - 1964   Bankhaus Friedrich Simon KGaA 
               Apprenticeship in banking 
 
 
 
 Membership of other statutory supervisory boards 
 
 Fresenius Management SE (Fresenius Group mandate until 05/2021) 
 
 
 
 Membership of comparable German or foreign supervisory bodies 
 
 none 
 
 
 

f) Hauke Stars Member of various supervisory boards

Member of the Supervisory Board of Fresenius SE & Co. KGaA since 2016

Date of Birth: June 3, 1967 Place of Birth: Merseburg Nationality: German

 
 
 
 
 Professional Experience 
 
 
 
                         Deutsche Börse AG 
                         Member of the Executive Board 
                         2018 - 2020 responsible for Human Resources / Labour Director 
 2012 - 2020 
                         2016 - 2020 responsible for Cash Market, Pre-IPO & Growth Financing 
 
                         2012 - 2015 responsible for the Information Technology and Market Data + Services Division 
 
 
 
 2004 - 2012             Hewlett Packard AG 
                         Last position: Managing Director Switzerland and Country Manager Enterprise Business 
 
 
 
                         Triaton GmbH 
 1998 - 2004             (formerly ThyssenKrupp Information System GmbH) 
                         Last position: Senior Vice President Sales and Marketing 
                         Member of Triaton Management Board 
 
 
 
 1992 - 1998             Bertelsmann mediaSystems GmbH 
                         Last Position: Executive Assistant to the CIO of Bertelsmann AG 
 
 
 
 Education 
 
 
 
 1991 - 1992   University of Warwick (UK) 
               MSc by Research in Engineering 
 
 1986 - 1991   Otto-von-Guericke Universität Magdeburg 
               Engineering degree in applied computer science (Dipl.-Ing.) 
 

Membership of other statutory supervisory boards

None Membership of comparable German or foreign supervisory bodies

Kühne + Nagel International AG^1

^1 Stock listed company

Data Protection Information

1. Controller, categories of processed data and purposes of data processing

Fresenius SE & Co. KGaA, Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H., Germany (the "Company"), email: ir-fre@fresenius.com, processes personal data (in particular name, first name, address, email address, number of shares, type of ownership of shares, number of the access card, and voting, and, as the case may be, name, first name and address of a proxy authorized by the respective shareholder) as controller in accordance with applicable data protection laws to enable shareholders to exercise their rights in the context of the Virtual Annual General Meeting. If shareholders or proxies contact the Company, the Company also processes the personal data necessary to respond to any requests (for example the contact data provided by the shareholder or proxy, such as email address or telephone number). If applicable, the Company also processes personal data relating to questions, statements, countermotions, election proposals and requests of shareholders or proxies in the context of the Virtual Annual General Meeting.

(MORE TO FOLLOW) Dow Jones Newswires

April 07, 2021 11:51 ET (15:51 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
AGCO CORPORATION 0.58% 151.88 Delayed Quote.47.33%
ALLIANZ SE 1.53% 218.75 Delayed Quote.8.99%
BASF SE 2.00% 72.45 Delayed Quote.11.94%
COMMERZBANK AG 1.23% 4.969 Delayed Quote.-5.64%
DEUTSCHE BANK AG 2.25% 10.442 Delayed Quote.16.68%
DEUTSCHE BöRSE AG -0.57% 147.6 Delayed Quote.6.00%
EVOTEC SE 0.15% 33.6 Delayed Quote.10.96%
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.13% 63.38 Delayed Quote.-7.07%
FRESENIUS SE & CO. KGAA 0.27% 38.455 Delayed Quote.1.63%
HEWLETT PACKARD ENTERPRISE COMPANY 0.69% 15.95 Delayed Quote.34.60%
SIEMENS AG 4.26% 145.96 Delayed Quote.24.20%
THYSSENKRUPP AG 1.33% 11.45 Delayed Quote.40.94%
UCB 1.66% 82.24 Real-time Quote.-2.65%
All news about FRESENIUS SE & CO. KGAA
04/16FRESENIUS  : 2020 SASB Mapping (PDF, 144 KB)
PU
04/14DGAP-ADHOC  : Nanogate SE: Stepping Down of the Chairman of the Supervisory Boar..
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -12-
DJ
04/07DGAP-AGM : Fresenius SE & Co. KGaA: Announcement -11-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -10-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -9-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -8-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -7-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -6-
DJ
04/07DGAP-AGM  : Fresenius SE & Co. KGaA: Announcement -5-
DJ
More news
Financials
Sales 2021 36 981 M 44 311 M 44 311 M
Net income 2021 1 771 M 2 122 M 2 122 M
Net Debt 2021 22 631 M 27 117 M 27 117 M
P/E ratio 2021 12,1x
Yield 2021 2,23%
Capitalization 21 440 M 25 683 M 25 690 M
EV / Sales 2021 1,19x
EV / Sales 2022 1,09x
Nbr of Employees 311 269
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 46,09 €
Last Close Price 38,46 €
Spread / Highest target 108%
Spread / Average Target 19,9%
Spread / Lowest Target -54,1%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Jürgen Götz Chief Legal & Compliance Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA1.63%25 582
AIER EYE HOSPITAL GROUP CO., LTD.-20.68%37 762
TOPCHOICE MEDICAL CORPORATION1.08%13 901
RAMSAY HEALTH CARE LIMITED8.27%11 932
IHH HEALTHCARE-2.00%11 403
BANGKOK DUSIT MEDICAL SERVICES0.00%11 330